Unknown OBSERVATIONAL NCT04287309

CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS

CAR-T Cellular Therapy for B Cell Malignancies Involved in Central Nervous System

Sponsor: Zhejiang University

Interventions CAR-T cells

Updated 7 times since 2020 Last updated: Feb 26, 2020 Started: Feb 28, 2020 Primary completion: Feb 28, 2022 Completion: Feb 28, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hematological Malignancy and is currently ongoing. Zhejiang University leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Apr 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Apr 2023 [monthly]

Recruiting
Jan 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
Mar 2020 — Nov 2020 [monthly]

Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhejiang University

Data source: Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China